{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:21:25Z","timestamp":1776054085656,"version":"3.50.1"},"reference-count":48,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2023,11,2]]},"DOI":"10.1080\/13543784.2023.2276755","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T16:25:04Z","timestamp":1698337504000},"page":"985-995","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Evaluating phase II results of Baxdrostat, an aldosterone synthase inhibitor for hypertension"],"prefix":"10.1080","volume":"32","author":[{"given":"Ayoola","family":"Awosika","sequence":"first","affiliation":[{"name":"College of Medicine, University of Illinois, Chicago, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoonje","family":"Cho","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Illinois, Chicago, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ujjal","family":"Bose","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, American University of Antigua, Antigua, Antigua, Barbuda, West Indies"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adekunle E.","family":"Omole","sequence":"additional","affiliation":[{"name":"Cell Biology and Anatomy, Louisiana State University, New Orleans, Louisiana, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uzochukwu","family":"Adabanya","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Edward Via College of Osteopathic Medicine, Monroe, Louisiana, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0244-2"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.008720"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214489"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101043440101"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.2735"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36184"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328363570c"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12051"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213169"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvz057"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.07806"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.07716"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(10)60584-0"},{"key":"e_1_3_5_16_1","first-page":"65","article-title":"LY3045697, a novel, potent, and selective inhibitor of aldosterone synthase, reduces aldosterone levels and shows potential for the treatment of hypertension and cardiovascular diseases","volume":"57","author":"Sloan-Lancaster J","year":"2017","unstructured":"Sloan-Lancaster J, Raddad E, Flynt A, et al. LY3045697, a novel, potent, and selective inhibitor of aldosterone synthase, reduces aldosterone levels and shows potential for the treatment of hypertension and cardiovascular diseases. J Clin Pharmacol. 2017;57:65\u201374.","journal-title":"J Clin Pharmacol"},{"key":"e_1_3_5_17_1","first-page":"994","article-title":"Antimineralocorticoid therapies for hypertension and heart failure","volume":"62","author":"Schumacher S","year":"2013","unstructured":"Schumacher S, Oo YA, Kurtz TW. Antimineralocorticoid therapies for hypertension and heart failure. Hypertension. 2013;62:994\u20131001.","journal-title":"Hypertension"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00851"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)30030-4"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610173351607"},{"key":"e_1_3_5_21_1","first-page":"200","article-title":"Abnormalities in corticosteroid synthesis: genetic and phenotypic spectrum","volume":"22","author":"Wagner J","year":"1984","unstructured":"Wagner J, White PC. Abnormalities in corticosteroid synthesis: genetic and phenotypic spectrum. Horm Res. 1984;22:200\u2013210.","journal-title":"Horm Res"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-022-01070-4"},{"key":"e_1_3_5_23_1","unstructured":"Eagle KA Efficacy and safety of baxdrostat in patients with uncontrolled hypertension \u2013 HALO [American College of Cardiology]. Mar 4 2023. [Cited Sep 26 2023] American College of Cardiology: https:\/\/www.acc.org\/latest-in-cardiology\/clinical-trials\/2023\/03\/01\/23\/34\/halo"},{"key":"e_1_3_5_24_1","unstructured":"Clinicaltrials.gov. A study to evaluate CIN-107 for the treatment of patients with uncontrolled hypertension and chronic kidney disease. CinCor Pharma Inc; 2023. [Cited Sep 26 2023] Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05432167"},{"key":"e_1_3_5_25_1","unstructured":"Clinicaltrials.gov. A study of CIN-107 in adults with primary aldosteronism. CinCor Pharma Inc; 2023. [Cited Sep 26 2023] Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04605549"},{"key":"e_1_3_5_26_1","unstructured":"Clinicaltrials.gov. A study to investigate the efficacy and safety of baxdrostat in Participants with uncontrolled hypertension on two or more medications including Participants with resistant hypertension (BaxHTN). CinCor Pharma Inc; 2023. [Cited Sep 26 2023] Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT06034743"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1124479"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-22-0375"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283455ca5"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020786"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.168427"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht095"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801483"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.190223"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0952-3278(99)80020-9"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1042\/CS20140758"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018226"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000384"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-023-00572-x"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.19744"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.272"},{"issue":"2","key":"e_1_3_5_42_1","first-page":"296","article-title":"Efficacy and safety of LCI699 for hypertension: a meta-analysis of randomized controlled trials and systematic review","volume":"19","author":"Wang H","year":"2015","unstructured":"Wang H, Tian J, Yang K. Efficacy and safety of LCI699 for hypertension: a meta-analysis of randomized controlled trials and systematic review. Eur Rev Med Pharmacol Sci. 2015;19(2):296\u2013304.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/sur010"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.07074"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpaa137"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.095489"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06768"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs257"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00622.2006"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.160960"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2023.2276755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T14:59:06Z","timestamp":1727276346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2023.2276755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,2]]}},"alternative-id":["10.1080\/13543784.2023.2276755"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2023.2276755","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-10-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}